A small amount of human cosmetic research exists, mainly in multi-ingredient skin formulations. That does not tell us how much benefit comes from acetyl octapeptide-3 itself, and it does not establish injectable or medical use.
Still uncertain: How much benefit comes from the ingredient itself, whether injectable use works, or any long-term therapeutic benefit of acetyl octapeptide-3 alone.
By confirming your subscription, you agree to receive occasional WhichPeps Evidence Updates. Kit processes the signup and email delivery for WhichPeps. Privacy. Unsubscribe anytime.
What does the evidence mean in simple terms? table
What is it?
Synthetic cosmetic octapeptide
Entity type
Peptide
Research focus
Topical cosmetic wrinkle research
Human evidence
Human cosmetic studies of microneedle formulations containing acetyl octapeptide-3 report wrinkle/skin-quality improvements, but the studied products also contained other active ingredients.
Regulatory status
Cosmetic ingredient rather than an approved injectable therapeutic.
Main limitations
The independent effect size, injectable efficacy, or long-term therapeutic benefit of acetyl octapeptide-3 alone.
Safety
Systemic/injectable safety is not established and should not be inferred from cosmetic topical use.
Evidence reviewed
2026-09-18
i
Human cosmetic studies of microneedle formulations containing acetyl octapeptide-3 report wrinkle/skin-quality improvements, but the studied products also contained other active ingredients.
Outcome-level evidence
Evidence is not one score.
Each record below answers a narrower question about an outcome, population or context. Evidence status and the study finding are shown separately so strong evidence is not mistaken for a positive effect.
Systemic/injectable safety is not established and should not be inferred from cosmetic topical use.
Topical cosmetic exposure is the relevant evidence context; systemic/injectable safety is not established.
Technical details
Mechanism / biologyDesigned as a cosmetic peptide intended to influence SNARE-associated neurotransmitter-release pathways at the skin surface.
Route / formulation boundaryProduct-level effects from multi-active microneedle formulations cannot be attributed wholly to acetyl octapeptide-3.
Identity / data-quality noteUse the canonical compound identity and studied formulation when interpreting evidence.
Study / label regimen evidenceStudy-regimen evidence reviewed. A human cosmetic study used a multi-ingredient microneedle product, so an isolated acetyl octapeptide-3 dose-response cannot be assigned.
WhichPeps does not rely on a single headline study when the evidence base is broader. Primary research, registries, regulators and supporting records are kept distinct.
2structured study records
2outcome records
4linked source records
How to read these counts: they show evidence coverage, not evidence strength. One large, well-designed study can be more informative than several weak or indirect records.
Show supporting and discovery sources
Study pages above contain the records used for public evidence summaries. The links below include supporting, regulatory and literature-discovery sources; a registry or search result is not treated as proof of benefit.
Evidence rule: WhichPeps keeps human, animal, laboratory, regulatory and product/formulation evidence distinct. Common names help people find the page; they do not change the underlying scientific identity.
